NO20004892D0 - Kinolin-4-yl-derivater I - Google Patents
Kinolin-4-yl-derivater IInfo
- Publication number
- NO20004892D0 NO20004892D0 NO20004892A NO20004892A NO20004892D0 NO 20004892 D0 NO20004892 D0 NO 20004892D0 NO 20004892 A NO20004892 A NO 20004892A NO 20004892 A NO20004892 A NO 20004892A NO 20004892 D0 NO20004892 D0 NO 20004892D0
- Authority
- NO
- Norway
- Prior art keywords
- quinolin
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/233—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/46—Nitrogen atoms attached in position 4 with hydrocarbon radicals, substituted by nitrogen atoms, attached to said nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurosurgery (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Psychology (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP99119539 | 1999-10-01 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| NO20004892D0 true NO20004892D0 (no) | 2000-09-29 |
| NO20004892L NO20004892L (no) | 2001-04-02 |
Family
ID=8239107
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20004892A NO20004892L (no) | 1999-10-01 | 2000-09-29 | Kinolin-4-yl-derivater I |
Country Status (26)
| Country | Link |
|---|---|
| US (1) | US6440995B1 (no) |
| JP (1) | JP3523174B2 (no) |
| KR (1) | KR100398561B1 (no) |
| CN (1) | CN1181059C (no) |
| AR (1) | AR025882A1 (no) |
| AT (1) | ATE281436T1 (no) |
| AU (1) | AU774363B2 (no) |
| BR (1) | BR0004548A (no) |
| CA (1) | CA2321324A1 (no) |
| CO (1) | CO5200789A1 (no) |
| CZ (1) | CZ20003575A3 (no) |
| DE (1) | DE60015471T2 (no) |
| ES (1) | ES2230017T3 (no) |
| HR (1) | HRP20000639A2 (no) |
| HU (1) | HUP0003861A3 (no) |
| ID (1) | ID27525A (no) |
| IL (1) | IL138777A0 (no) |
| MA (1) | MA26752A1 (no) |
| NO (1) | NO20004892L (no) |
| NZ (1) | NZ507141A (no) |
| PE (1) | PE20010648A1 (no) |
| PL (1) | PL342876A1 (no) |
| PT (1) | PT1088818E (no) |
| SG (1) | SG164268A1 (no) |
| TR (1) | TR200002831A2 (no) |
| ZA (1) | ZA200005239B (no) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6831087B2 (en) * | 2001-11-09 | 2004-12-14 | Hoffmann-La Roche Inc. | Pyridine substituted isoquinoline derivatives |
| EP1476429B1 (en) * | 2002-02-13 | 2005-11-16 | F. Hoffmann-La Roche Ag | Novel pyridine- and quinoline-derivatives |
| JP2008506695A (ja) * | 2004-07-13 | 2008-03-06 | グラクソ グループ リミテッド | 抗細菌剤 |
| WO2009042907A1 (en) * | 2007-09-27 | 2009-04-02 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Isoindoline compounds for the treatment of spinal muscular atrophy and other uses |
| ES2769648T3 (es) * | 2014-06-16 | 2020-06-26 | Fundacion Para La Investig Medica Aplicada | Nuevos compuestos como inhibidores duales de histona metiltransferasas y ADN metiltransferasasASAS |
| EP3206689B1 (en) | 2014-10-14 | 2021-12-08 | La Jolla Institute of Allergy & Immunology | Inhibitors of low molecular weight protein tyrosine phosphatase and uses thereof |
| KR20170074178A (ko) * | 2015-12-21 | 2017-06-29 | 제이엔씨 주식회사 | 중합성 액정 화합물, 조성물, 그 액정 중합막류 및 이들의 용도 |
| CN105646462B (zh) * | 2016-01-19 | 2019-04-05 | 河南大学 | 芸香宁碱衍生物、其制备方法及应用 |
| WO2018204176A1 (en) | 2017-05-01 | 2018-11-08 | Sanford Burnham Prebys Medical Discovery Institute | Inhibitors of low molecular weight protein tyrosine phosphatase (lmptp) and uses thereof |
| TW202304917A (zh) * | 2021-03-26 | 2023-02-01 | 美商賽迪拉治療股份有限公司 | Ｔｅａｄ抑制劑及其用途 |
| JP2023139414A (ja) * | 2022-03-22 | 2023-10-04 | 東レ株式会社 | フェナントロリン誘導体の製造方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE440008C (de) | 1924-03-29 | 1927-05-04 | I G Farbenindustrie Akt Ges | Verfahren zur Darstellung von Chinolinderivaten |
| US4560692A (en) | 1984-07-18 | 1985-12-24 | Hoffmann-La Roche Inc. | 4-Piperidino-2-phenylquinolines |
| GB9125515D0 (en) | 1991-11-29 | 1992-01-29 | Merck Sharp & Dohme | Therapeutic agents |
| US5441963A (en) | 1991-12-20 | 1995-08-15 | Merrell Dow Pharmaceuticals | Potentiation of NMDA antagonists |
-
2000
- 2000-09-11 US US09/658,934 patent/US6440995B1/en not_active Expired - Fee Related
- 2000-09-26 NZ NZ507141A patent/NZ507141A/en unknown
- 2000-09-26 DE DE60015471T patent/DE60015471T2/de not_active Expired - Fee Related
- 2000-09-26 MA MA26068A patent/MA26752A1/fr unknown
- 2000-09-26 AT AT00120890T patent/ATE281436T1/de not_active IP Right Cessation
- 2000-09-26 PT PT00120890T patent/PT1088818E/pt unknown
- 2000-09-26 ES ES00120890T patent/ES2230017T3/es not_active Expired - Lifetime
- 2000-09-27 CA CA002321324A patent/CA2321324A1/en not_active Abandoned
- 2000-09-27 AU AU61324/00A patent/AU774363B2/en not_active Ceased
- 2000-09-27 SG SG200005551-7A patent/SG164268A1/en unknown
- 2000-09-27 CZ CZ20003575A patent/CZ20003575A3/cs unknown
- 2000-09-27 CO CO00073351A patent/CO5200789A1/es not_active Application Discontinuation
- 2000-09-28 ZA ZA200005239A patent/ZA200005239B/xx unknown
- 2000-09-28 AR ARP000105102A patent/AR025882A1/es not_active Application Discontinuation
- 2000-09-28 IL IL13877700A patent/IL138777A0/xx unknown
- 2000-09-28 CN CNB001292013A patent/CN1181059C/zh not_active Expired - Fee Related
- 2000-09-28 HR HR20000639A patent/HRP20000639A2/hr not_active Application Discontinuation
- 2000-09-28 PE PE2000001024A patent/PE20010648A1/es not_active Application Discontinuation
- 2000-09-29 BR BR0004548-9A patent/BR0004548A/pt not_active IP Right Cessation
- 2000-09-29 KR KR10-2000-0057259A patent/KR100398561B1/ko not_active Expired - Fee Related
- 2000-09-29 NO NO20004892A patent/NO20004892L/no unknown
- 2000-09-29 ID IDP20000849D patent/ID27525A/id unknown
- 2000-09-29 TR TR2000/02831A patent/TR200002831A2/xx unknown
- 2000-09-29 PL PL00342876A patent/PL342876A1/xx not_active Application Discontinuation
- 2000-09-29 HU HU0003861A patent/HUP0003861A3/hu unknown
- 2000-09-29 JP JP2000298078A patent/JP3523174B2/ja not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| JP3523174B2 (ja) | 2004-04-26 |
| JP2001097952A (ja) | 2001-04-10 |
| AR025882A1 (es) | 2002-12-18 |
| CA2321324A1 (en) | 2001-04-01 |
| AU774363B2 (en) | 2004-06-24 |
| ES2230017T3 (es) | 2005-05-01 |
| HUP0003861A3 (en) | 2002-09-30 |
| HU0003861D0 (en) | 2000-12-28 |
| CN1181059C (zh) | 2004-12-22 |
| AU6132400A (en) | 2001-04-05 |
| CO5200789A1 (es) | 2002-09-27 |
| KR20010050738A (ko) | 2001-06-15 |
| DE60015471T2 (de) | 2005-10-27 |
| CZ20003575A3 (cs) | 2001-11-14 |
| PL342876A1 (en) | 2001-04-09 |
| PT1088818E (pt) | 2005-03-31 |
| NZ507141A (en) | 2002-05-31 |
| US6440995B1 (en) | 2002-08-27 |
| KR100398561B1 (ko) | 2003-09-19 |
| TR200002831A3 (tr) | 2001-04-20 |
| BR0004548A (pt) | 2001-05-29 |
| TR200002831A2 (tr) | 2001-04-20 |
| SG164268A1 (en) | 2010-09-29 |
| HUP0003861A2 (hu) | 2001-10-28 |
| ZA200005239B (en) | 2001-04-16 |
| HRP20000639A2 (en) | 2001-06-30 |
| PE20010648A1 (es) | 2001-06-13 |
| DE60015471D1 (de) | 2004-12-09 |
| ID27525A (id) | 2001-04-12 |
| CN1290698A (zh) | 2001-04-11 |
| NO20004892L (no) | 2001-04-02 |
| MA26752A1 (fr) | 2004-12-20 |
| IL138777A0 (en) | 2001-10-31 |
| ATE281436T1 (de) | 2004-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20000885D0 (no) | 4-Fenyl-pyridin-derivater | |
| NO20021077D0 (no) | Amino-triazolopyridin-derivater | |
| ATE263748T1 (de) | Admantan-derivate | |
| DE50010060D1 (de) | Thiazolylamid-derivate | |
| IS6128A (is) | 13-Metýl-erýþrómýsín afleiður | |
| DK1187814T3 (da) | 5-phenyl-pyrimidinderivater | |
| ATE338021T1 (de) | Substituierte 2-dialkylaminoalkylbiphenyl- derivate | |
| NO20021803L (no) | Isoksazolkarboksamid-derivater | |
| ATE257148T1 (de) | Propargyletherderivate | |
| DK1154988T3 (da) | Mevinolinderivater | |
| ATE374747T1 (de) | Monofluoralkylderivate | |
| DK1187815T3 (da) | 4-phenyl-pyrimidinderivater | |
| ATE254598T1 (de) | 4-hydroxybiphenylhydrazid-derivate | |
| ATE293592T1 (de) | Resorcinderivate | |
| NO20005031D0 (no) | Kinolin-4-yl-derivater II | |
| NO20004892D0 (no) | Kinolin-4-yl-derivater I | |
| DK1189886T3 (da) | Ethansulfonyl-piperidinderivater | |
| DK1088818T3 (da) | Quinolin-4-yl-derivater | |
| NO20020212L (no) | 3-amino-2-benzyl-1-fenyl-propanderivater | |
| NO20022867D0 (no) | Syklopentenon-derivater | |
| DE60001736D1 (de) | 1-trifluorotmethyl-4-hydroxy-7-piperidinyl-aminomethylchroman-derivate | |
| DE59909774D1 (de) | 1-cycloalkylpyrazolyl-benzoyl-derivate |